imputed cost【会计】 - PMC

Qing Xia, Julie A. Campbell, Hasnat Ahmad, Barbara de Graaff, Lei Si, Petr Otahal, Kevin Ratcliffe, Julie Turtle, John Marrone, Mohammed Huque, Barry Hagan, Matthew Green, Andrew J. Palmer

Eur J Health Econ. 2022; 23(6): 941–952. Published online 2021 Nov 12. doi: 10.1007/s10198-021-01405-x

PMCID:: PMC8586836

Article PDF–1015K

Select item 99855865.

Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease

B. Rodríguez-Sánchez, S. Daugbjerg, L. M. Peña-Longobardo, J. Oliva-Moreno, I. Aranda-Reneo, A. Cicchetti, J. López-Bastida

Eur J Health Econ. 2023; 24(2): 247–277. Published online 2022 May 20. doi: 10.1007/s10198-022-01471-9

PMCID:: PMC9985586

Article PDF–793K

Select item 66765606.

Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique

Sergi Alonso, Olga Cambaco, Yolanda Maússe, Graça Matsinhe, Eusébio Macete, Clara Menéndez, Elisa Sicuri, Esperança Sevene, Khátia Munguambe

BMC Public Health. 2019; 19: 1031. Published online 2019 Aug 1. doi: 10.1186/s12889-019-7338-4

PMCID:: PMC6676560

Article PDF–782K

Select item 63945347.

Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment

Health Quality Ontario

Ont Health Technol Assess Ser. 2019; 19(6): 1–199. Published online 2019 Feb 19.

PMCID:: PMC6394534

Article PDF–1.6M

Select item 91301788.

Zsombor Zrubka, Márta Péntek, Lea Mhanna, Teebah Abu-Zahra, Mohamed Mahdi-Abid, Meriem Fgaier, Faris El-Dahiyat, Hana Al-Abdulkarim, Michael Drummond, László Gulácsi

Pharmacoeconomics. 2022; 40(6): 587–599. Published online 2022 May 17. doi: 10.1007/s40273-022-01146-6

PMCID:: PMC9130178

Article PDF–948K

Select item 74279749.

Certificate of need laws: a systematic review and cost-effectiveness analysis

Christopher J. Conover, James Bailey

BMC Health Serv Res. 2020; 20: 748. Published online 2020 Aug 14. doi: 10.1186/s12913-020-05563-1

PMCID:: PMC7427974

Article PDF–1.0M

Select item 842875810.

The effectiveness and cost‐effectiveness of hospital‐based specialist palliative care for adults with advanced illness and their caregivers

Cochrane Database Syst Rev. 2020; 2020(9): CD012780. Published online 2020 Sep 30. doi: 10.1002/14651858.CD012780.pub2

PMCID:: PMC8428758

Article PDF–2.9M

Select item 583659711.

Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

Health Quality Ontario

Ont Health Technol Assess Ser. 2018; 18(2): 1–160. Published online 2018 Feb 21.

PMCID:: PMC5836597

Article PDF–1.9M

Select item 680842112.

Cost-effectiveness and social outcomes of a community-based treatment for podoconiosis lymphoedema in the East Gojjam zone, Ethiopia

Natalia Hounsome, Meseret Molla Kassahun, Moses Ngari, James A. Berkley, Esther Kivaya, Patricia Njuguna, Greg Fegan, Abreham Tamiru, Abebe Kelemework, Tsige Amberbir, Annabelle Clarke, Trudie Lang, Melanie J. Newport, Andy McKay, Fikre Enquoselassie, Gail Davey

PLoS Negl Trop Dis. 2019 Oct; 13(10): e0007780. Published online 2019 Oct 23. doi: 10.1371/journal.pntd.0007780

PMCID:: PMC6808421

Article PDF–988K

Select item 613671113.

Influence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia

Sergio Bautista-Arredondo, Sandra G. Sosa-Rubi, Marjorie Opuni, David Contreras-Loya, Gina La Hera-Fuentes, Ada Kwan, Claire Chaumont, Abson Chompolola, Jeanine Condo, Kumbutso Dzekedzeke, Omar Galarraga, Neil Martinson, Felix Masiye, Sabin Nsanzimana, Richard Wamai, Joseph Wang’ombe, on behalf of the ORPHEA study team

PLoS One. 2018; 13(9): e0203121. Published online 2018 Sep 13. doi: 10.1371/journal.pone.0203121

PMCID:: PMC6136711

Article PDF–4.2M

Select item 632479214.

Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand

Tony Blakely, Giorgi Kvizhinadze, June Atkinson, Joseph Dieleman, Philip Clarke

PLoS Med. 2019 Jan; 16(1): e1002716. Published online 2019 Jan 8. doi: 10.1371/journal.pmed.1002716

PMCID:: PMC6324792

Article PDF–1.6M

Select item 623507715.

Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment

Health Quality Ontario

Ont Health Technol Assess Ser. 2018; 18(7): 1–199. Published online 2018 Oct 24.

PMCID:: PMC6235077

Article PDF–2.3M

Select item 883630416.

Cost-utility analysis of community occupational therapy in dementia (COTiD-UK) versus usual care: Results from VALID, a multi-site randomised controlled trial in the UK

Elena Pizzo, Jennifer Wenborn, Jane Burgess, Jacqueline Mundy, Martin Orrell, Michael King, Rumana Omar, Stephen Morris

PLoS One. 2022; 17(2): e0262828. Published online 2022 Feb 11. doi: 10.1371/journal.pone.0262828

PMCID:: PMC8836304

Article PDF–579K

Select item 996922817.

Abstracts 2022 North American Meeting for the Society of Medical Decision Making, October 23-26, 2022

Med Decis Making. 2023 Apr; 43(3): NP1–NP474. Published online 2023 Feb 25. doi: 10.1177/0272989X231153042

PMCID:: PMC9969228

Article PDF–31M

Select item 486441118.

Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa

Helen Cox, Lebogang Ramma, Lynne Wilkinson, Virginia Azevedo, Edina Sinanovic

Trop Med Int Health. 2015 Oct; 20(10): 1337–1345. Published online 2015 Jun 1. doi: 10.1111/tmi.12544

PMCID:: PMC4864411

Article PDF–173K

Select item 649113919.

Interventions to increase attendance for diabetic retinopathy screening

John G Lawrenson, Ella Graham‐Rowe, Fabiana Lorencatto, Jennifer Burr, Catey Bunce, Jillian J Francis, Patricia Aluko, Stephen Rice, Luke Vale, Tunde Peto, Justin Presseau, Noah Ivers, Jeremy M Grimshaw, Cochrane Eyes and Vision Group

Cochrane Database Syst Rev. 2018; 2018(1): CD012054. Published online 2018 Jan 15. doi: 10.1002/14651858.CD012054.pub2

PMCID:: PMC6491139

Article PDF–1.7M

Select item 855330620.

The costs of bipolar disorder in the United Kingdom

Judit Simon, Anees A. Abdul Pari, Jane Wolstenholme, Michael Berger, Guy M. Goodwin, John R. Geddes

Brain Behav. 2021 Oct; 11(10): e2351. Published online 2021 Sep 15. doi: 10.1002/brb3.2351

PMCID:: PMC8553306

Article PDF–1.0M

<< First< Prev

Page of 1767

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for imputed cost【会计】

Figure 3Cost effectiveness acceptability curves with total cost data based on questionnaire responses (base case analysis), and total cost data with imputed missing values (imputed total cost data).

An occupational health intervention programme for workers at high risk for sickness absence. Cost effectiveness analysis based on a randomised controlled trial

Occup Environ Med. 2008 Apr;65(4):242-248.
Figure 2Cost effectiveness planes. Base case results indicated by a diamond. (A) With cost data based on the survey responses. In 49.9% of simulated cases intervention was both cost saving and more effective (Quadrant IV), in 17.7% cost saving and less effective (Quadrant III), in 12.5% more costly and more effective (Quadrant II), and in 19.9% of cases more costly and less effective (Quadrant I). (B) With missing cost data imputed. In 89.5% of simulated cases intervention was both cost saving and more effective (Quadrant IV), in 0.9% cost saving and less effective (Quadrant III), in 8.7% more costly and more effective (Quadrant II), and in 0.9% of cases more costly and less effective (Quadrant I).

An occupational health intervention programme for workers at high risk for sickness absence. Cost effectiveness analysis based on a randomised controlled trial

Occup Environ Med. 2008 Apr;65(4):242-248.
Figure 4Cost of PSC according to diagnostic categories (DS).

*Other: Was assigned an imputed cost equal to the weighted average cost for a patient with known cause of PSC with the same level of severity. PSC: Peristomal Skin Complication. DS: Dialogue Study.

Peristomal Skin Complications Are Common, Expensive, and Difficult to Manage: A Population Based Cost Modeling Study

PLoS One. 2012;7(5):e37813.
Figure 2

Cost effectiveness acceptability curves for pooled imputed and complete data (costs are reported in euros). (A) Bootstrap SFS_OE at 12 months; (B) Bootstrap QALY at 12 months.

Cost Effectiveness and Budget Impact of the Boston University Approach to Psychiatric Rehabilitation for Increasing the Social Participation of Individuals With Severe Mental Illnesses

Front Psychiatry. 2022;13:880482.